GU Cancers 2018 | MRI and MRI-directed biopsies for the diagnosis of prostate cancer

Mark Emberton

The utilization of MRI for the diagnosis of prostate cancer in men at risk is relatively new. In this interview, filmed at the 2018 Genitourinary Cancers Symposium, in San Francisco, CA, Mark Emberton, MD, FRCS, of University College London, London, UK, explains why the use of MRI is important for the diagnosis and treatment of prostate cancer. Prof. Emberton also explains the problems that can arise from not determining tumor location and volume at diagnosis.

Share this video  
Similar topics
Related videos
3:16
Impact of new TKIs on NSCLC treatment planning
Nicolas Girard
1:58
A commonly used molecular cancer imaging technique
Sanjiv Gambhir
2:11
Exhaled breath signatures for lung cancer detection: the LuCID study
Robert Rintoul
0:58
Checkpoint inhibitors for head and neck cancer in the definitive setting?
Barbara Burtness
5:03
Reducing diagnostic delay for better cancer outcomes
Richard Neal
Genitourinary Cancer, Prostate Cancer
GU Cancers 2018
Interview
8th February 2018
More from Mark Emberton
Is delayed diagnosis in the UK to blame for poorer cancer outcomes?
Is it possible to destroy the cancer while preserving the prostate?
An MRI-based approach to prostate cancer diagnosis: a urologist’s stance in the debate
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals